Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
Rhea-AI Summary
Bioventus (Nasdaq: BVS) will report first-quarter fiscal 2026 financial results before market open on May 6, 2026. Management will host a conference call at 8:30 a.m. ET the same day and provide a live webcast and materials via the company investor relations site. The webcast will be archived through May 5, 2027.
Positive
- None.
Negative
- None.
News Market Reaction – BVS
In the Apr 29 session, BVS declined 2.91%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 24 | Earnings date notice | Neutral | +0.3% | Set Q4 2025 results date with conference call and webcast details. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings-date scheduling news produced a small positive move, suggesting these notices have historically been low-impact catalysts.
This announcement sets the first-quarter fiscal 2026 earnings date, continuing Bioventus’s pattern of pre-announcing results and hosting calls with webcasts and replays. Earlier, Q4 and full-year 2025 results on March 5, 2026 showed revenue growth and guidance that drew a 7.44% move, while Q3 2025 earnings on November 4, 2025 saw a 15.09% reaction. Conference appearances in late 2025 and early 2026 generated modest price changes, underscoring that full results, not scheduling notices, have been the stronger drivers.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2026 before the market opens on Wednesday, May 6, 2026. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call.
A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until May 5, 2027.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and X. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com
